Tizanidine Tablet
Product Images NDC 50090-7716

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 50090-7716). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (356b3e79 D47b 467a Af62 2adca35f1a2f 01)

Chemical structure of tizanidine hydrochloride, showing the molecular arrangement with chlorine, sulfur, nitrogen atoms, and hydrogen chloride (HCl).*

FDA Label Image

Image (356b3e79 D47b 467a Af62 2adca35f1a2f 02)

A line graph depicting plasma tizanidine concentration (ng/mL) over 24 hours post-dosing. It compares four groups: 2 x 4 mg tizanidine tablets with food, 2 x 4 mg tablets without food, 2 x 4 mg tizanidine capsules with food, and 2 x 4 mg capsules without food. Concentration peaks between 1-2 hours and decreases thereafter.*

FDA Label Image

Image (356b3e79 D47b 467a Af62 2adca35f1a2f 03)

A line graph showing the improvement in Ashworth Score over 6 hours post-dose for 16 mg tizanidine, 8 mg tizanidine, and placebo groups. The y-axis represents improvement in Ashworth Score, while the x-axis represents hours post-dose. The 16 mg dose shows the greatest improvement, peaking around 2 hours. Error bars are displayed for each data point.*

FDA Label Image

Image (356b3e79 D47b 467a Af62 2adca35f1a2f 04)

A line chart comparing improvement in Ashworth Score between tizanidine (mean dose 28.8 mg) and placebo over three study points: end of titration (week 3), end of maintenance (week 7), and endpoint (last observation carried forward). The chart shows mean improvement scores with error bars, indicating greater improvement for tizanidine compared to placebo at all time points.*

FDA Label Image

Label Image (Lbl500907716)

Tizanidine 2 mg oral tablets label from A-S Medication Solutions. The label shows the product number 5443-0, NDC 50090-7716-0, and indicates each tablet contains 2.258 mg tizanidine hydrochloride equivalent to 2 mg tizanidine. The package contains 30 tablets and storage instructions specify to store at 77 degrees Fahrenheit. The label includes a QR code and packaging location in Libertyville, Illinois.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.